Please try another search
Kunshan Kersen Science & Technology Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 764.36 million compared to CNY 523.08 million a year ago. Revenue was CNY 764.36 million compared to CNY 523.08 million a year ago. Net loss was CNY 70.99 million compared to CNY 83.66 million a year ago. Basic loss per share from continuing operations was CNY 0.13 compared to CNY 0.15 a year ago. Diluted loss per share from continuing operations was CNY 0.13 compared to CNY 0.15 a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 684.16 | 523.08 | ||
Gross Profit | 76.78 | 52.51 | ||
Operating Income | -73.89 | -55.48 | -53.93 | |
Net Income | -70.99 | -121.28 | -83.66 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 5282.92 | 5362.73 | 5205 | |
Total Liabilities | 2458.05 | 2416.16 | 2182.79 | |
Total Equity | 2824.87 | 2946.57 | 3022.21 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 260.34 | 305.49 | ||
Cash From Investing Activities | -118 | -178.07 | ||
Cash From Financing Activities | -120.88 | -91.46 | ||
Net Change in Cash | 24.35 | 24.59 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review